Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
COVID-19 and myocarditis: a systematic review and overview of current challenges.
Heart Fail Rev
January 2022
Royal Brompton Hospital, Imperial College London, London, UK.
Myocardial inflammation in COVID-19 has been documented. Its pathogenesis is not fully elucidated, but the two main theories foresee a direct role of ACE2 receptor and a hyperimmune response, which may also lead to isolated presentation of COVID-19-mediated myocarditis. The frequency and prognostic impact of COVID-19-mediated myocarditis is unknown.
View Article and Find Full Text PDFClinical and epidemiological aspects of cardiomyopathies: a critical review of current knowledge.
Eur J Intern Med
February 2003
Department of Internal Medicine, University of Tor Vergata, Rome, Italy
Five years after the second report of the WHO/ISFC Task Force on the definition and classification of cardiomyopathies (CM), a critical review of the matter appears well-timed. The need for a correct definition of myocardial diseases is emphasized by considering them the result of a 'direct' injury due to different known and unknown causes and not a consequence of ischemic disease or of pressure and/or volume overload. This is in order to eliminate terms like ischemic CM, valvular CM, and hypertensive CM, which are a source of confusion.
View Article and Find Full Text PDF[Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation].
Med Klin (Munich)
April 1998
Abteilung Innere Medizin-Schwerpunkt Kardiologie, Philipps-Universität Marburg.
In the report of the 1995 WHO/ISFC task force on the definition and classification of cardiomyopathies a new entity within the dilated cardiomyopathies was introduced as "inflammatory cardiomyopathy". It is defined as myocarditis associated with cardiac dysfunction. Idiopathic, autoimmune and infectious forms of inflammatory cardiomyopathy are now recognized through this definition.
View Article and Find Full Text PDF[Current knowledge of cardiomyopathy].
Med Pregl
February 1998
Klinika za kardiologiju, Medicinski fakultet, Novi Sad.
In 1961, 1964 and 1970, Goodwin proposed a somewhat unwield definition of cardiomyopathies, which was subsequently shortened to "Heart muscle disease of unknown cause" and separated from heart muscle diseases due to conditions involving organs other than the heart: the "specific heart muscle diseases". The cardiomyopathies thus defined were divided into hypertrophic, dilated and restrictive types and their classification was confirmed by the WHO/ISFC Task Force and the report of the WHO Expert Committee on cardiomyopathies in 1984. The cardiomyopathies are now classified by the dominant pathophysiology or where possible by aetiological/pathogenic factors.
View Article and Find Full Text PDFStrategy for controlling rheumatic fever/rheumatic heart disease, with emphasis on primary prevention: memorandum from a joint WHO/ISFC meeting.
Bull World Health Organ
October 1996
This Memorandum summarizes the report of a meeting held in Geneva on 7-9 September 1994. Experts and representatives from different countries and regions, as well as WHO, the International Society and Federation of Cardiology, UNESCO, and the International Council of Nurses evaluated the experience in controlling rheumatic fever/rheumatic heart disease (RF/RHD) and provided an update on the essential components of RF/RHD prevention, including new areas for research in primary prevention. The meeting's recommendations should be applicable in all countries where RF/RHD is a health problem.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!